{"schema":"hottub-news/story/v1","story":"st_w7ze7jwho3o2bwraz6yq","title":"2026 IMS Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody IBI3003 (GPRC5D/BCMA/CD3) in Patients with Relapsed or Refractory Multiple Myeloma","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/2026-ims-oral-presentation-innovent-announces-updated-phase-1-clinical-w7ze7jwho3","count":1,"items":[{"id":"n_w7ze7jwho3o2bwraz6yq","seq":615584,"kind":"article","title":"2026 IMS Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody IBI3003 (GPRC5D/BCMA/CD3) in Patients with Relapsed or Refractory Multiple Myeloma","url":"https://www.prnewswire.com/news-releases/2026-ims-oral-presentation-innovent-announces-updated-phase-1-clinical-data-of-trispecific-antibody-ibi3003-gprc5dbcmacd3-in-patients-with-relapsed-or-refractory-multiple-myeloma-302892611.html","published":"2026-09-29T08:15:00Z","seen":"2026-09-29T08:15:20Z","lang":"en","source":{"id":"prnewswire.com","name":"prnewswire.com","domain":"prnewswire.com","outlet":{"wikidata":"Q376399","name":"PR Newswire","type":"other","country":"US","designations":["business","information resource"]}},"via":"gdelt-gkg-english","topics":["economy","education"],"authors":["Innovent Biologics"],"entities":[{"id":"Q30296199","name":"Innovent","type":"org"}],"story":"st_w7ze7jwho3o2bwraz6yq","category":"health","category_p":0.5299999713897705,"category2":"science-technology","sentiment":"neutral","tone":0.019999999552965164,"political":0.03999999910593033}]}